Karina Cuellar
Family · San Antonio, TXNPI 1326814450
Payments from drug & device makers
Across 198 payments — averaging $24.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AbbVie$881
- AstraZeneca$529
- Lilly USA, LLC$508
- Bayer$489
- Amgen$453
- plus $976 from 13 others
What the payments were for
- Food & beverage$4,894100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 40 | $1,057 |
| AbbVie | 47 | $881 |
| AstraZeneca | 17 | $529 |
| Lilly USA, LLC | 22 | $508 |
| Bayer | 17 | $489 |
| Amgen | 8 | $453 |
| Dexcom, Inc. | 10 | $308 |
| Pfizer | 19 | $214 |
| Teva Pharmaceuticals USA, Inc. | 2 | $155 |
| Shield Therapeutics Inc | 3 | $54 |
| Phadia US Inc. | 2 | $46 |
| Mannkind Corporation | 2 | $38 |
| GSK | 2 | $36 |
| Antares Pharma, Inc. | 2 | $36 |
| Sanofi-aventis U.S. LLC | 1 | $24 |
| Exact Sciences | 1 | $17 |
| Boehringer Ingelheim | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Repatha$275
- Kerendia$245
- Wegovy$239
- DEXCOM G7 GSS (161)$150
- DEXCOM STELO GLUCOSE BIOSENSOR$150
- FARXIGA$125
- MOUNJARO$125
- VRAYLAR$125
- Austedo XR$125
- Ozempic$125
- ZEPBOUND$125
- Otezla$119
How this compares
$4,894 in reported general payments places this provider in the 90th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 29 | $445 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 12 | $210 |
| Levothyroxine Sodium | 15 | $185 |
| Metoprolol Succinate | 11 | $172 |
| Methylprednisolone | 21 | $144 |
| Atorvastatin Calcium | 13 | $128 |
| Losartan Potassium | 11 | $93 |
| Ciprofloxacin Hcl | 15 | $91 |
| Azithromycin | 24 | $81 |
| Metformin Hcl | 14 | $77 |
Paid to pharmacies, not to this prescriber.
Other family in San Antonio
- Anna CastroSan Antonio$184K
- Natalia FariasSan Antonio$124K
- Ayoade AvworoSan Antonio$111K
- Tina CoppleSan Antonio$97K
- Kim HinojosaSan Antonio$63K
- Kimberly GibergaSan Antonio$36K
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.